baber/WOPTO huggingface dataset:
Patent CA-2498973-A1 (CA)
Title: Nutritional formula containing select carotenoid combinations
Inventor: BOFF JEFFREY M
IPC: A23L33/00
Filed: 2005-02-28
Abstract: Disclosed are nutritional formulas, including reconstitutable powders, comprising carbohydrate, protein and a lipid component containing a polyunsaturated fatty acid; and from abou t 0.25 to about 10 ppm, by weight of the total oil content of the infant formula, of a combination of lutein, lycopene, and beta- carotene with preferred weight ratios of the lutein to beta-carotene of from about 0.0196:1 to about 59:1, the lycopene to beta-carotene of from about 0.00805:1 to about 114:1, and th e lutein to lycopene of from about 0.0117:1 to about 108:1. Also disclosed are methods of providing nutrition using the disclosed formulas. The nutritional formulas provide improved product stability and color characteristics.
Patent CA-2503150-A1 (CA)
Inventor: RAVIVARAPU HARISH
IPC: A61K31/7072
Filed: 2003-10-31
Abstract: L'invention concerne des formulations orales de produits pharmaceutiques de biodisponibilité améliorée par ciblage de régions spécifiques du tractus gastro-intestinal. En particulier, des médicaments hydrosolubles et acido-labiles tels que des analogues de cytidine (par exemple, la décitabine) et des analogues de 2'-déoxyadénosine (par exemple la pentostatine) sont formulés avec des polymères sensibles au pH de façon que ces médicaments soient de préférence absorbés dans les régions supérieures du petit intestin, comme le jéjunum. De plus, les médicaments de pauvre biodisponibilité orale tel que les composés de la camptothécine (par exemple la 9- nitro-camptothécine) peuvent aussi être formulés au moyen de stratégies similaires de façon à améliorer de façon importante leur biodisponibilité orale. On peut utiliser ces formulations afin de traiter une grande variété de maladies ou de troubles, tells que des troubles hématologique, des tumeurs bénignes, le cancer, la resténose, des maladies inflammatoires et des maladies auto-immunes.
Patent CA-2505062-A1 (CA)
Inventor: COVA JEAN-FRANCOIS
IPC: G06K9/00
Filed: 2003-11-03
Abstract: The invention relates to a method for identification of a person by recognition of a digital fingerprint, whereby the characteristic points on a digitised image of a digital fingerprint (E) are determined and transmitted (16) to a bank holding (17) the characteristic points of a number of digital fingerprints for comparison and identification (18) of the person to whom the photographed fingerprint belongs. When the fingerprint (E) is taken on a curved surface (3) of an object (12), the digitised mage is transformed (13) into a plane-projection corrected digitised image, by means of an algorithm, in which the characteristic points are detected (15).
Patent CA-2505249-A1 (CA)
Title: N-sulfonylaminothiazole
Inventor: SCHREINER ERWIN PAUL
IPC: A61P29/00
Filed: 2003-11-13
Abstract: N-(4,5,6,7-tetrahydro-thiazolo-[5,4-c]pyridin-2-yl)-(C6-18)arylsulfonamides, wherein the nitrogen atom of the pyridine is substituted, and wherein the pyridine ring is optionally bridged, useful as a pharmaceutical related to steroid sulfatase.
Patent CA-2505947-A1 (CA)
Inventor: SCHERTLER KURT
IPC: B61G5/00
Filed: 2005-05-02
Abstract: An assembly for fastening a transportation device of a cableway system, such as a cabin or a chair, on a suspension bar, which is formed at its upper end with a running mechanism, with a coupling clamp, interacting with the conveying cable or traction cable of the cableway system, and with a guide roller, the transportation device also being provided at its upper end with a supporting device, by way of which it is articulated on the lower end of the suspension bar in a way allowing it to be pivoted transversely with respect to the conveying cable or traction cable. The articulation of the transportation device on the lower end of the suspension bar is formed by two links, which are located at a distance from each other transversely in relation to the conveying cable or traction cable and run obliquely upward in relation to each other, their free ends being articulated on the one hand on the supporting device and on the other hand on the lower end of the suspension bar. (Fig. 1)
Patent CA-2508985-A1 (CA)
Title: Composes immunomodulateurs ramifies et leur procedes d'utilisation
Inventor: FEARON KAREN L
IPC: A61K48/00
Filed: 2003-12-17
Abstract: La présente invention a trait à des composés immunomodulateurs et des procédés pour l'immunomodulation des cellules et des individus mettant en oeuvre ces composés immunomodulateurs.
Patent CA-2510132-A1 (CA)
Inventor: GUPTA ANIL KUMAR
IPC: A01N45/00
Filed: 2002-12-16
Abstract: La présente invention se rapporte à l'activité de stimulation de la croissance que présentent la calliterpénone, élément actif naturel d'origine végétale, et ses dérivés, qui font partie du groupe des diterpénoïdes phyllocladanes. Ces substances phytochimiques et leurs dérivés exercent une très forte activité de stimulation de la croissance sur des racines et des pousses végétales, et favorisent la germination des graines, et ce chez les plantes tant monocotylédones que dicotylédones. Lesdites molécules végétales exercent une activité antagoniste contre des substances allélochimiques ralentissant la croissance végétale, et peuvent donc être utilisées pour en atténuer les effets nocifs.
Patent CA-2511408-A1 (CA)
Inventor: NEUHAUS RONALD W
IPC: F16J15/10
Filed: 2005-07-04
Abstract: An expansion ring assembly for sealing a gasket with respect to an annular wall of a rigid structure. The expansion ring assembly includes a drive mechanism for engaging and driving apart the opposing ends of an expansion ring to thereby radially expand the ring. The drive mechanism generally includes a pair of block members, formed of steel or a rigid plastic, for example, having oppositely threaded bores therethrough, and a bolt having oppositely threaded ends which are threaded within respective threaded bores of the block members. The block members are interlockingly engaged with respective opposite ends of the expansion ring. Rotation of the bolt in a first direction simultaneously drives the block members apart from one another along the bolt to radially expand the expansion ring, and rotation of the bolt in a an opposite, second direction simultaneously drives the block members toward one another along the bolt to allow the expansion ring to radially contract.
Patent CA-2513601-A1 (CA)
Title: Tkts as modifiers of the beta-catenin pathway and methods of use
Inventor: LICKTEIG KIM
IPC: C12N5/09
Filed: 2004-01-28
Abstract: Human TKT genes are identified as modulators of the beta-catenin pathway, and thus are therapeutic targets for disorders associated with defective beta-catenin function. Methods for identifying modulators of beta-catenin, comprising screening for agents that modulate the activity of TKT are provided.
Patent CA-2514115-A1 (CA)
Title: Cell separation apparatus
Inventor: TAKAHASHI KAZUNORI
IPC: C12M1/42
Filed: 2004-04-30
Abstract: A cell analysis separation apparatus that does not damage cell samples, preventing the attrition of electrode for applying a voltage for cell separation and that in prolonged separation, does not cause clogging of channels. In particular, a cell separation apparatus comprising means for migrating cells in a cell separation space by applying external force to the cells from outside and a channel capable of cell separation and discharge so as to prevent the damaging of cell samples and prevent the attrition of electrode by electrolysis. As the means for applying external force, there can preferably be mentioned application of electric field to the space for cell separation with the use of electrolyte-containing gel electrode. Further, in this cell separation apparatus a filter can be disposed at an upstream portion of a channel wherein a fluid containing a sample to be fed into the cell separation space is introduced so that impurities can be trapped to thereby avoid channel clogging.
Patent CA-2514190-A1 (CA)
Inventor: HILL RUSSELL
IPC: C04B18/06
Filed: 2004-01-22
Abstract: A method of producing cementitious mixtures containing fly ash as one of the cementitious components, under air entrainment conditions. The method involves forming a mixture comprising water, cement, fly ash, optionally other cementitious materials, aggregate, conventional chemical admixtures, and an air entrainment agent and agitating the mixture to entrain air therein.  Additionally, at least one sacrificial agent is also included in the mixture.  The sacrificial agent is a material or mixture of materials that is not required to act as an air entrainment agent but interacts preferentially with components of the fly ash that otherwise neutralize, repress or depress the activity of the air entrainment agent. The invention includes cementitious mixtures and hardened concretes resulting from the method and fly ash treated with sacrificial agent, or air entrainment agent/sacrificial agent combinations, and processes for selecting suitable sacrificial agents.
Patent CA-2515349-A1 (CA)
Title: Copy protection for applications
Inventor: JACKSON MARK DOMINIC
IPC: G06F21/60
Filed: 2004-02-19
Abstract: Published without an Abstract
Patent CA-2522283-A1 (CA)
Inventor: SCHIMMER MARTIJN
IPC: G01S13/87
Filed: 2004-04-08
Abstract: When playing a sport it is generally difficult to localize (exactly) an accessory required for that sport at a determined point in time. The localizing of sports equipment may however be desired in particular situations, for instance to track down lost articles of sports equipment, or to be able to apply the rules of a sport in efficient manner. The invention therefore relates to a system for localizing sports equipment. The invention also relates to a method for localizing sports equipment using such a system.
Patent CA-2524478-A1 (CA)
Title: Lipid platinum complexes and methods of use thereof
Inventor: TRUNEH ALEMSEGED
IPC: A61K/
Filed: 2004-05-03
Abstract: This invention provides novel lipid platinum complexes, liposomally encapsulated lipid platinum complexes, pharmaceutical compositions comprising a lipid platinum complex, and methods for treating cancer using a lipid platinum complex. Kits comprising a unit dosage form of a compound or composition of the invention are also provided.
Patent CA-2526137-A1 (CA)
Title: Rod assembly in ion source
Inventor: IZGARIAN NICOLAE
IPC: H01J49/16
Filed: 2004-05-25
Abstract: Ion source assemblies for generating ions for laser desorption mass spectrometry. An ion source assembly (100) includes a target (117) for receiving analyte samples (20) and a plurality of rods (111, 112). The rods define an interior volume having an axis (113) extending away from a surface of the target for transporting ions. One or more of the rods include an aperture (115) defining an opening through a cross-section of the rod. The aperture is configured such that a laser beam can pass through the aperture to irradiate a location on the target surface to generate ions from an analyte sample deposited at the location.
Patent CA-2527040-A1 (CA)
Inventor: WALLACE JOHN S
IPC: B65G47/52
Filed: 1997-06-11
Abstract: An apparatus and method for providing a masking, insulating and/or lubricating barrier coating on a portion of the threads and/or other surfaces of discrete objects such as fasteners utilizing a liquid coating material as provided. The present invention can selectively coat threaded and/or unthreaded surfaces of fasteners having odd shapes, deep threads and extended hubs. The fasteners are subsequently elevated and inverted onto a conveying system that moves them away from the area where the coating material is applied directly into a heat treatment device such as an oven in a continuous on-line process that does not require manual handling of the fasteners.
Patent CA-2529464-A1 (CA)
Title: Propionamide derivatives useful as androgen receptor modulators
Inventor: MOILANEN ANU
IPC: C07C/
Filed: 2004-06-24
Abstract: Compounds of formula (I) wherein R1 to R4, X and A are as defined in the claims and pharmaceutically acceptable salts and esters thereof, are disclosed. The compounds of formula (I) possess utility as tissue-selective androgen receptor modulators (SARM) and are useful in hormonal therapy, e.g.  in the treatment or prevention of male hypogonadism and age-related conditions such as andropause.
Patent CA-2530439-A1 (CA)
Title: Process for the production of esters from epoxides
Inventor: HEPTING JOSEPH
IPC: C07C67/26
Filed: 2004-06-29
Abstract: The present invention relates to a process comprising the steps of reacting in the presence of an epoxide opening catalyst, a substituted epoxide, and preferably a silicone containing substituted epoxide with at least one carboxylic acid and at least one protecting agent to form a vicinal dialkyl ester or a vicinal disilyl ester.
Patent CA-2532011-A1 (CA)
Inventor: YOUD JASON B
IPC: F01L1/46
Filed: 2006-01-09
Abstract: A damper is shown for damping the movements of a valve spring in an engine. The damper comprises a body that is adapted to fit over the bottom end of a valve spring or, in another embodiment, within the body of a valve spring. The damper body comprises a plurality of slots in the side wall of the body creating a plurality of wall sections. The slots can be angled at a predetermined angle away from the axis of the body. Where the damper is placed over the bottom end of the valve spring at least one spring steel ring is wrapped around the damper body and seated into a groove in the damper body side wall. The ring is available in a number of configurations having concavo-convex dimples or indentations that are adapted to create enhanced pressure points on the sidewall of the damper body and hence modify the frictional engagement between the outside wall of the valve spring and the inside surface of the damper sidewall.
Patent CA-2532306-A1 (CA)
Inventor: STEIN ROBERT
IPC: E06B1/56
Filed: 2006-01-06
Abstract: A window kit composed of molded components contains all the parts necessary to install a finished window in an window opening of a building, particularly a pre-fabricated structure. The kit includes a one piece outside frame, a one piece inside frame and a panel spanning the frames. The inside frame and the outside frame have cooperating fasteners to secure the frames together with the panel and the edges of the building opening between them. The panel has complementary apertures to the cooperating fasteners to secure the panel in the frames.
Patent CA-2535230-A1 (CA)
Title: Subterranean fluids and methods of using these fluids in subterranean formations
Inventor: BROTHERS LANCE E
IPC: E21B33/13
Filed: 2004-07-26
Abstract: The present invention provides subterranean fluids comprising a hydraulic cement in an invert emulsion, and methods of using such fluids in subterranean well cementing operations. The fluids comprise a hydraulic cement and an invert emulsion of oil, water, and a surfactant. Optionally, other ingredients may be included in the fluids.
Patent CA-2535965-A1 (CA)
Inventor: KENT ANDREW
IPC: H01L43/00
Filed: 2004-08-18
Abstract: The present invention describes a high-speed and low-power method by which a spin-polarized electrical current can be used to control and switch the magnetization direction of a magnetic region in such a device. The magnetic device comprises a pinned magnetic layer (FM1) with fixed magnetization direction, a free magnetic layer (FM2) with free magnetization direction, and a read-out magnetic layer (FM3) with fixed magnetization direction. The pinned layer (FM1) and free layer (FM2) are separated by a non-magnetic layer (N1), and the free layer (FM2) and read-out layer (FM3) are separated by another non-magnetic layer (N2). The non-magnetic layers minimize the magnetic interaction between the magnetic layers. A current is applied to the device to induce a torque that alters the magnetic state or resistance of the device for writing information. The resistance is measured to thereby read out the information stored in the device.
Patent CA-2536106-A1 (CA)
Inventor: JONES DOUG
IPC: H04H20/77
Filed: 2004-09-07
Abstract: Method and system for out-of-band (OOB) messaging with customer premises equipment (CPE) (22) configured to receive OOB messaging signals from a cable modem termination system (CMTS) (42). The method and system include determining whether a downstream channel descriptor (DCD) message identifying data tunnels include a DCD message identifier matching with a CPE identifier such that the data tunnels identified in the matching DCD message are tuned to by the CPE (22).
Patent CA-2540659-A1 (CA)
Inventor: WILKE NICHOLAS JEROME II
IPC: D04H1/26
Filed: 2004-09-29
Abstract: The present invention relates to absorbent tissue-towel paper products comprising one essentially continuous ply of fibrous structure having a first surface and a second surface, wherein the product has an HFS absorbency greater than 8 g/g and the first surface exhibits an embossment height of at least 650 ~m and the second surface exhibits an embossment height of at least about 650 ~m.
Patent CA-2541793-A1 (CA)
Inventor: HAUPT DIETER
IPC: H04N5/92
Filed: 2006-04-05
Abstract: Various applications record or handle uncompressed video, where the amount of information needed for each frame or field is constant, based on the video frame rate and colour resolution of each pixel. Since various video frame rates and audio sample rates are defined and can be combined independently, the amount of audio samples per video frame may vary. The disclosed method allows packing audio samples and video samples into constant size containers, e.g. MXF containers, so that there is an integer amount of audio samples within the time period needed for one video frame, independent from the used video raster. The method includes generating constant length KLV encoded video packets (PicI), generating variable length KLV encoded audio packets (AudI) corresponding to the same time period as the video packets (PicI), generating variable length KLV encoded data packets (DatI), wherein the sum of the lengths of the audio packet and the data packet are constant, and generating from said packets a constant size content package (CP_1,...,CP_N).
Patent CA-2543305-A1 (CA)
Inventor: SOREQ HERMONA
IPC: A61K31/7088
Filed: 2004-10-26
Abstract: The present invention provides a novel use for AChE antisense oligonucleotides as anti-inflammatory agents, wherein said oligonucleotides are preferably as denoted by SEQ. ID. NO:1, SEQ. ID. NO:2 and SEQ. ID. NO:7. Described are pharmaceutical compositions for the treatment of inflammatory conditions, as well as methods of treatment thereof, comprising as active agent said AChE  antisense oligonucleotides.
Patent CA-2547670-A1 (CA)
Title: Treating infectious diseases using ice inhibitors
Inventor: KU GEORGE
IPC: A61K31/5513
Filed: 2004-12-01
Abstract: This invention relates to methods and compositions for treating infectious and other diseases, particularly of the eye, by administering an ICE inhibitor.  This invention also relates to methods for treating injuries, allergies, chemical irritations, or burns of the eye by administering an ICE inhibitor.
Patent CA-2547771-A1 (CA)
Title: Microfluidic methods, devices and systems for in situ material concentration
Inventor: CHIEN RING-LING
IPC: G01N1/40
Filed: 2004-12-06
Abstract: Methods of concentrating materials within microfluidic channel networks by moving materials into regions in which overall velocities of the material are reduced, resulting in stacking of the material within those reduced velocity regions. These methods, devices and systems employ static fluid interfaces to generate the differential velocities, as well as counter-current flow methods, to concentrate materials within microscale channels.
Patent CA-2549300-A1 (CA)
Title: Electrically actuated variable pressure control system
Inventor: HENDERSON GRAEME W
IPC: G05D16/20
Filed: 2006-06-02
Abstract: An electrically-actuated variable pressure control system for use with flow-controlled liquid application systems. Direct acting solenoid valves are pulsed at varying frequencies and duty cycles0000change the resistance to flow encountered by the flow-controlled liquid application system. This pulsing solenoid valve technique preserves a high degree of accuracy and uniformity through a wide range of pressure control. This wide range of pressure control indirectly allows the flow-controlled liquid application system to operate over a wider range of flow control, yielding indirect benefits to performance and productivity. When the solenoid valves are attached to pressure-atomization spray nozzles, control over spray pattern and droplet size is further achieved.
Patent CA-2549631-A1 (CA)
Inventor: JAIN SANJAY
IPC: G09F3/10
Filed: 2004-12-22
Abstract: La présente invention concerne un formulaire de gestion (20) banalisable, convenant notamment à l'environnement médical ou hospitalier. Dans un premier mode de réalisation il comporte un bracelet pourvu d'une zone (46) réservée aux étiquettes, recouverte d'une partie laminée, chacune présentant au moins un passage de sangle (44) par laquelle il est possible de passer l'extrémité libre (34) pour fixer le bracelet au membre de l'individu. Les différentes variantes de fermeture de la sangle (42) selon l'invention concerne un volet repliable, ou deux volets, ou un passage de sangle supplémentaire, ou des perforations avec une fermeture à pression. Les étiquettes (50) et le bracelet peuvent chacun porter en impression une marque d'identification telle qu'un code à barres. En outre, les éléments du formulaire sont disposés de façon à pouvoir être agencés en une bande continue, relativement étroite, se prêtant aisément au traitement par imprimante thermique.
Patent CA-2552790-A1 (CA)
Title: Process for the purification of bacterially expressed proteins
Inventor: ROSSI MARA
IPC: C12N15/19
Filed: 2004-01-19
Abstract: This patent application relates to a process for the purification of proteins expressed in prokaryotic cells, which comprises interposing a reverse phase chromatography step between the extraction/denaturation and the renaturation steps.
Patent CA-2553739-A1 (CA)
Inventor: ALARCO JOSE ANTONIO
IPC: C01G3/02
Filed: 2005-01-24
Abstract: A method of producing porous complex oxides includes the steps of providing a mixture of a) precursor elements suitable to produce the complex oxide; or b ) one or more precursor elements suitable to produce particles of the complex oxide and one or more metal oxide particles; and c) a particulate carbon- containing pore-forming material selected to provide pore sizes in the range of approximately 7 nm to 250 nm, and treating the mixture to (i) form the porous complex oxide in which two or more of the precursor elements from (a) above or one or more of the precursor elements and one or more of the metals in the metal oxide particles from (b) above are incorporated into a phase of the complex metal oxide and the complex metal oxide has grain sizes in the range of about 1 nm to 150 nm; and (ii) remove the pore-forming material und er conditions such that the porous structure and composition of the complex oxi de is substantially preserved. The method may be used to produce non-refractory metal oxides as well.
Patent CA-2555463-A1 (CA)
Title: Inhibitors of tgf-r signaling for treatment of cns disorders
Inventor: BOGDAHN ULRICH
IPC: C12Q1/68
Filed: 2005-02-09
Abstract: The present invention relates to the use of oligonucleotides for the preparation of a pharmaceutical composition for the prevention or treatment of a disease, wherein neurogenesis and/or neuroregeneration has a beneficial effect, in particular a disease like Morbus Alzheimer, Morbus Parkinson, Lewy Body Dementia,-Amyotrophic Lateral Sclerosis, Spinocerebellar Atrophies, Creutzfeldt Jakob Disease, Frontemporal Dementia, Morbus Pick, AIDS Dementia Complex, Vascular Dementia, Progressive Supranuclear Palsy, Corticobasal Degeneration, Multisystem-Atrophy, Hallervorden Spatz Disease, Huntington~s disease, Stroke, Traumatic Brain and spinal cord Injury, Retinitis Pigmentosa, Macular Degeneration, Glaucoma, Cochlea Degeneration, Depression, Schizophrenia, Multiple Sclerosis, and developmental neurodegeneration.